Source: Investing.com ↗

Eli Lilly’s $100B incretin opportunity: Is more upside coming?

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.02%

BTC/USDT

$85,786.25

-0.29%

ETH/USDT

$2,730.45

-0.60%

ZEC/USDT

$1,619.00

+7.14%

XRP/USDT

$1.59

+3.73%